Selected research
Industry Research
Glucoraphanin Industry Research Report 2026
Market perspective
The global Glucoraphanin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glucoraphanin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glucoraphanin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glucoraphanin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glucoraphanin include CS Health, Brassica Protection Product（BPP）, Pioneer Herb Industrial, Nutramax Laboratories, Shenzhen Fushan Biotechnology, Chengdu SanHerb BioScience, Xi`an App-Chem Bio (Tech), Wellgreen Technology and Anhui Bensentang Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glucoraphanin market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glucoraphanin Market by Company
CS Health
Brassica Protection Product（BPP）
Pioneer Herb Industrial
Nutramax Laboratories
Shenzhen Fushan Biotechnology
Chengdu SanHerb BioScience
Xi`an App-Chem Bio (Tech)
Wellgreen Technology
Anhui Bensentang Biotechnology
Glucoraphanin Segment by Type
<10% Glucoraphanin
10-15% Glucoraphanin
>15% Glucoraphanin
Glucoraphanin Segment by Application
Health Products
Functional Foods
Pharmaceutical
Others
Glucoraphanin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucoraphanin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucoraphanin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucoraphanin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glucoraphanin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glucoraphanin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glucoraphanin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- <10% Glucoraphanin
- 10-15% Glucoraphanin
- >15% Glucoraphanin
Applications
- Health Products
- Functional Foods
- Pharmaceutical
- Others
Companies covered
- CS Health
- Brassica Protection Product（BPP）
- Pioneer Herb Industrial
- Nutramax Laboratories
- Shenzhen Fushan Biotechnology
- Chengdu SanHerb BioScience
- Xi`an App-Chem Bio (Tech)
- Wellgreen Technology
- Anhui Bensentang Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glucoraphanin Market Size (2021-2032)
- 2.2.2 Global Glucoraphanin Sales (2021-2032)
- 2.2.3 Global Glucoraphanin Market Average Price (2021-2032)
- 2.3 Glucoraphanin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 <10% Glucoraphanin
- 2.3.3 10-15% Glucoraphanin
- 2.3.4 >15% Glucoraphanin
- 2.4 Glucoraphanin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Health Products
- 2.4.3 Functional Foods
- 2.4.4 Pharmaceutical
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glucoraphanin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glucoraphanin Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Glucoraphanin Revenue of Manufacturers (2021-2026)
- 3.4 Global Glucoraphanin Average Price by Manufacturers (2021-2026)
- 3.5 Global Glucoraphanin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glucoraphanin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glucoraphanin, Product Type & Application
- 3.8 Global Manufacturers of Glucoraphanin, Established Date
- 3.9 Global Glucoraphanin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 CS Health
- 4.1.1 CS Health Company Information
- 4.1.2 CS Health Business Overview
- 4.1.3 CS Health Glucoraphanin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 CS Health Glucoraphanin Product Portfolio
- 4.1.5 CS Health Recent Developments
- 4.2 Brassica Protection Product（BPP）
- 4.2.1 Brassica Protection Product（BPP） Company Information
- 4.2.2 Brassica Protection Product（BPP） Business Overview
- 4.2.3 Brassica Protection Product（BPP） Glucoraphanin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Brassica Protection Product（BPP） Glucoraphanin Product Portfolio
- 4.2.5 Brassica Protection Product（BPP） Recent Developments
- 4.3 Pioneer Herb Industrial
- 4.3.1 Pioneer Herb Industrial Company Information
- 4.3.2 Pioneer Herb Industrial Business Overview
- 4.3.3 Pioneer Herb Industrial Glucoraphanin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pioneer Herb Industrial Glucoraphanin Product Portfolio
- 4.3.5 Pioneer Herb Industrial Recent Developments
- 4.4 Nutramax Laboratories
- 4.4.1 Nutramax Laboratories Company Information
- 4.4.2 Nutramax Laboratories Business Overview
- 4.4.3 Nutramax Laboratories Glucoraphanin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nutramax Laboratories Glucoraphanin Product Portfolio
- 4.4.5 Nutramax Laboratories Recent Developments
- 4.5 Shenzhen Fushan Biotechnology
- 4.5.1 Shenzhen Fushan Biotechnology Company Information
- 4.5.2 Shenzhen Fushan Biotechnology Business Overview
- 4.5.3 Shenzhen Fushan Biotechnology Glucoraphanin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shenzhen Fushan Biotechnology Glucoraphanin Product Portfolio
- 4.5.5 Shenzhen Fushan Biotechnology Recent Developments
- 4.6 Chengdu SanHerb BioScience
- 4.6.1 Chengdu SanHerb BioScience Company Information
- 4.6.2 Chengdu SanHerb BioScience Business Overview
- 4.6.3 Chengdu SanHerb BioScience Glucoraphanin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chengdu SanHerb BioScience Glucoraphanin Product Portfolio
- 4.6.5 Chengdu SanHerb BioScience Recent Developments
- 4.7 Xi`an App-Chem Bio (Tech)
- 4.7.1 Xi`an App-Chem Bio (Tech) Company Information
- 4.7.2 Xi`an App-Chem Bio (Tech) Business Overview
- 4.7.3 Xi`an App-Chem Bio (Tech) Glucoraphanin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Xi`an App-Chem Bio (Tech) Glucoraphanin Product Portfolio
- 4.7.5 Xi`an App-Chem Bio (Tech) Recent Developments
- 4.8 Wellgreen Technology
- 4.8.1 Wellgreen Technology Company Information
- 4.8.2 Wellgreen Technology Business Overview
- 4.8.3 Wellgreen Technology Glucoraphanin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Wellgreen Technology Glucoraphanin Product Portfolio
- 4.8.5 Wellgreen Technology Recent Developments
- 4.9 Anhui Bensentang Biotechnology
- 4.9.1 Anhui Bensentang Biotechnology Company Information
- 4.9.2 Anhui Bensentang Biotechnology Business Overview
- 4.9.3 Anhui Bensentang Biotechnology Glucoraphanin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Anhui Bensentang Biotechnology Glucoraphanin Product Portfolio
- 4.9.5 Anhui Bensentang Biotechnology Recent Developments
5 Global Glucoraphanin Market Scenario by Region
- 5.1 Global Glucoraphanin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glucoraphanin Sales by Region: 2021-2032
- 5.2.1 Global Glucoraphanin Sales by Region: 2021-2026
- 5.2.2 Global Glucoraphanin Sales by Region: 2027-2032
- 5.3 Global Glucoraphanin Revenue by Region: 2021-2032
- 5.3.1 Global Glucoraphanin Revenue by Region: 2021-2026
- 5.3.2 Global Glucoraphanin Revenue by Region: 2027-2032
- 5.4 North America Glucoraphanin Market Facts & Figures by Country
- 5.4.1 North America Glucoraphanin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glucoraphanin Sales by Country (2021-2032)
- 5.4.3 North America Glucoraphanin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Glucoraphanin Market Facts & Figures by Country
- 5.5.1 Europe Glucoraphanin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glucoraphanin Sales by Country (2021-2032)
- 5.5.3 Europe Glucoraphanin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Glucoraphanin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glucoraphanin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glucoraphanin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glucoraphanin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glucoraphanin Market Facts & Figures by Country
- 5.7.1 South America Glucoraphanin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glucoraphanin Sales by Country (2021-2032)
- 5.7.3 South America Glucoraphanin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Glucoraphanin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glucoraphanin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glucoraphanin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glucoraphanin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Glucoraphanin Sales by Type (2021-2032)
- 6.1.1 Global Glucoraphanin Sales by Type (2021-2032) & (t)
- 6.1.2 Global Glucoraphanin Sales Market Share by Type (2021-2032)
- 6.2 Global Glucoraphanin Revenue by Type (2021-2032)
- 6.2.1 Global Glucoraphanin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glucoraphanin Revenue Market Share by Type (2021-2032)
- 6.3 Global Glucoraphanin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glucoraphanin Sales by Application (2021-2032)
- 7.1.1 Global Glucoraphanin Sales by Application (2021-2032) & (t)
- 7.1.2 Global Glucoraphanin Sales Market Share by Application (2021-2032)
- 7.2 Global Glucoraphanin Revenue by Application (2021-2032)
- 7.2.1 Global Glucoraphanin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glucoraphanin Revenue Market Share by Application (2021-2032)
- 7.3 Global Glucoraphanin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glucoraphanin Value Chain Analysis
- 8.1.1 Glucoraphanin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glucoraphanin Production Mode & Process
- 8.2 Glucoraphanin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glucoraphanin Distributors
- 8.2.3 Glucoraphanin Customers
9 Global Glucoraphanin Analyzing Market Dynamics
- 9.1 Glucoraphanin Industry Trends
- 9.2 Glucoraphanin Industry Drivers
- 9.3 Glucoraphanin Industry Opportunities and Challenges
- 9.4 Glucoraphanin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst